Neuroprotection and aging of the cholinergic system: A role for the ergoline derivative nicergoline (Sermion®)

Neuroscience

Volumn 109, Issue 3, 2002, Pages 487-497

  Giardino, L ^a   Giuliani, A ^a   Battaglia, A ^b   Carfagna, N ^b   Aloe, L ^c   Calza L ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Pharmacia Corporation   (Italy)

^c CNR   (Italy)

^d HESPERIA HOSPITAL   (Italy)

Author keywords

Acetylcholine; Basal forebrain; Colchicine; Neurotrophins; Rat

Indexed keywords

CHOLINE ACETYLTRANSFERASE; COLCHICINE; MESSENGER RNA; NERVE GROWTH FACTOR; NICERGOLINE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FOREBRAIN; MALE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; COGNITION DISORDERS; COLCHICINE; DOWN-REGULATION; MALE; NERVE DEGENERATION; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; NICERGOLINE; NITRIC OXIDE SYNTHASE; NOOTROPIC AGENTS; RATS; RNA, MESSENGER; SEPTAL NUCLEI;

EID: 0037074885     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00470-5     Document Type: Article

References (80)

1. The Trk family of neurotrophin receptors
2. The neurobiological effects of colchicine: Modulation by nerve growth factor
3. Presynaptic markers of cholinergic function in the rat brain: Relationship with age and cognitive status
4. NADPH diaphorase-containing striatal or cortical neurons are resistant to apoptosis
5. The mechanism of action of colchicine. Binding of colchicine-3H to cellular protein
6. Multiple sclerosis patients express increased levels of nerve growth factor in cerebrospinal fluid
7. NO and brain aging
8. LNGFR expression in the basal forebrain of adult rats
9. Pharmacological basis for the clinical effects of nicergoline in dementia
10. Nicergoline and its metabolite induce translocation of PKC isoforms in selective rat brain areas
11. Modulation of hippocampal Ach release by chronic nicergoline treatment in freely moving young and aged rats
12. Modulation of phosphoinositide turnover by chronic nicergoline in rat brain
13. Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment
14. Nicergoline stimulates protein kinase C mediated alpha-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cells
15. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease
16. Increased vulnerability of septal cholinergic neurons to partial loss of target neurons in aged rats
17. Expression of BDNF and trkB as a function of age and cognitive performance
18. Nicergoline: Parallel evolution of clinical trial methodology and drug development in dementias
19. Hippocampal NGF levels are not reduced in the aged Fischer 344 rat
20. Trophic factor effects on cholinergic innervation in the cerebral cortex of the adult rat brain
21. Effect of colchicine on transport of amine storage granules in sympathetic nerves of rat
22. Evidence that Alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide
23. Role of forebrain cholinergic systems in learning and memory: Relevance to the cognitive deficits of aging and Alzheimer's dementia
24. Quantitative EEG analysis of nicergoline effects in elderly subjects
25. NGF improves spatial memory in aged rodents as a function of age
26. Nitric oxide synthase mRNA regulation by nicergoline treatment in the brain of old rats
27. Exogenous administration of L-arginine protects cholinergic neurons from colchicine neurotoxicity
28. Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system
29. Neurotoxic effects of colchicine: Differential susceptibility of CNS neuronal populations
30. Neurochemical aspects on aging and diseases with cognitive impairment
31. Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide
32. Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: Contrasting anatomical and cellular localization
33. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia
34. NOS induction by NGF in basal forebrain cholinergic neurones: Evidence for regulation of brain NOS by a neurotrophin
35. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle
36. Regulation of the cerebral microcirculation during neural activity: Is nitric oxide the missing link?
37. Protective effects of nicergoline against hydrogen peroxide toxicity in rat neuronal cell line
38. Neuropathology of Alzheimer's disease: A critical update
39. Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: A comparison to those of nerve growth factor and neurotrophin-3
40. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling
41. Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons
42. Neuronal dynamics and axonal flow. IV. Blockage of intra-axonal enzyme transport by colchicine
43. Nerve growth factor pharmacology: Application to the treatment of cholinergic neurodegeneration in Alzheimer's disease
44. BDNF and trkB mRNA expression in the hippocampal formation of aging rats
45. Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain
46. Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: Effects of nicergoline
47. Relationship of APP mRNA transcripts and levels of NGF and low-affinity NGF receptors to behavioral measures of ages-related cognitive dysfunction
48. Human nerve growth factor improves spatial memory in aged but not in young rats
49. Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels
50. 14C-plastic standard for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm
51. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative disease
52. Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain
53. Cholinergic deficits in aged rat brain are corrected with nicergoline
54. Leukaemia inhibitory factor prevents loss of p75-nerve growth factor receptor immunoreactivity in medial septal neurons following fimbria-fornix lesions
55. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury
56. Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75
57. The impact of L-arginine-nitric oxide metabolism on ischemia/reperfusion injury
58. Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS
59. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats
60. Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderly
61. Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry
62. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: A double-blind, placebo-controlled, clinical and EEG/ERP mapping study
63. Age-related changes in rodent cortical acetylcholine and cognition: Main effects of age versus age as an intervening variable
64. Nootropic drugs: Animal models for studying effects on cognition
65. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: A useful tool to produce cortical cholinergic dysfunction
66. Comparison of intracranial infusion of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain
67. Pharmacological study of nicergoline: Effects on regional cerebral blood flow
68. Janus faces of nitric oxide
69. Tyrosine kinase A, galanin and nitric oxide synthase within basal forebrain neurons in the rat
70. Neuroprotective effects of nicergoline in immortalized neurons
71. Immunohistochemical and neurochemical correlates of learning deficits in aged rats
72. Pituitary adenylate cyclase-activating polypeptide promotes the survival of basal forebrain cholinergic neurons in vitro and in vivo: Comparison with effects of nerve growth factor
73. Antioxidant properties of nicergoline: Inhibition of brain autooxidation and superoxide production neurophils in rats
74. Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors
75. Distribution and relative density of p75 nerve growth factor receptors in the rat brain as a function of age and treatment with antibodies to nerve growth factor
76. Lesions induced expression of low-affinity NGF-binding protein (p75) immunoreactivity after neonatal and adult aspiration lesions of the rat dorsomedial prefrontal cortex
77. Thyroxine increases nerve growth factor concentration in adult mouse brain
78. BDNF protection of basal forebrain cholinergic neurons after axotomy: Complete protection of p75NGFR-positive cells
79. Nicergoline in dementia. A review of its pharmacological properties and therapeutic potential